Amyloid-β fibril disruption by C60—molecular guidance for rational drug design
- 23 April 2012
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 14 (24) , 8599-8607
Abstract
The WHO has listed Alzheimer's disease among the major neurological disorders with an estimated 35 million people affected worldwide. Amyloid-β is mostly believed to be the causative factor in Alzheimer's disease and the severity of the disease correlates with the tendency of amyloid-β to form aggregation patterns—plaques. Lacking effective medication, the identification of any underlying mechanistic principles regarding plaque formation appears to be crucial. Here we carry out computer simulations to study the effect of C60 on structure and stability of an idealised pentameric construct of amyloid-β units (a model fibril). A binding site on top of the structurally ordered stack of β-sheets is identified that triggers structural alterations at the turn region of the hook-like β-sheet assembly. Significant structural alterations are: (i) the destruction of regular helical twist, (ii) the loss of a stabilizing salt bridge and (iii) the loss of a stabilizing hydrophobic interaction close to the turn. Consequently, the main effect of C60 is the induction of sizable destabilization in native fibril structure. These structural insights may serve as a molecular guide for further rational drug design of effective inhibitors targeting fibril formation in Alzheimer's disease.Keywords
This publication has 35 references indexed in Scilit:
- Fast Calculation of Electrostatic Potentials on the GPU or the ASIC MD-GRAPE-3The Computer Journal, 2010
- Carbon nanotubes prevent 2,2,2 trifluoroethanol induced aggregation of proteinCarbon, 2007
- Nucleation of protein fibrillation by nanoparticlesProceedings of the National Academy of Sciences, 2007
- PatchDock and SymmDock: servers for rigid and symmetric dockingNucleic Acids Research, 2005
- Fullerene inhibits β-amyloid peptide aggregationBiochemical and Biophysical Research Communications, 2003
- A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMRProceedings of the National Academy of Sciences, 2002
- Efficient Unbound Docking of Rigid Molecules2002
- Structural and Dynamic Features of Alzheimer's Aβ Peptide in Amyloid Fibrils Studied by Site-directed Spin LabelingJournal of Biological Chemistry, 2002
- Assembling amyloid fibrils from designed structures containing a significant amyloid β-peptide fragmentBiochemical Journal, 2002
- Molecular Structure of a Fibrillar Alzheimer's Aβ FragmentBiochemistry, 2000